David S. Baldwin, MD

Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, United Kingdom; College Keep, Southern Health NHS Foundation Trust, Southampton, United Kingdom; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa

  • 12Articles
  • 42.2KReads1
  • 1998–2026Active
  • 100Collaborators
  • 23Citations2

About

David S. Baldwin, MD, DM, is affiliated with the University of Southampton and the University of Cape Town. He has published extensively on depression, panic disorder, posttraumatic stress disorder, suicide risk, and psychiatry, focusing on topics such as treatment-resistant depression, antidepressant-induced sexual dysfunction, and placebo response in anxiety and mood disorders. His work includes analyses of symptom thresholds, neurotransmitter roles in depression, and consensus statements on panic disorder. Baldwin has collaborated frequently with researchers including Borwin Bandelow and Dan J. Stein.

Publications

JCP
The ASCP Task Force Consensus Statement on Combination Psychopharmacology
Consensus Statement

The ASCP Task Force Consensus Statement on Combination Psychopharmacology

November 9, 2026

Expert guidance to help practitioners identify clinically driven principles that shape coherent multi-drug regimens.
, , , et al
PCC
Impairment of Sexual Desire in Treatment-Resistant Depression
Original Research

Impairment of Sexual Desire in Treatment-Resistant Depression

November 22, 2022

Patients with treatment-resistant depression had a high prevalence of sexual desire impairment, which was associated with male sex and higher depressive symptom severity.
, , , et al
JCP
Original Research

Separation Anxiety and Suicide Risk

March 16, 2021

The link between suicidality and interpersonal difficulties extends the traditional approach of comprehending suicide as mainly related to depression. This study of adult outpatients investigated the link between separation...
, , , et al
JCP
Original Research

A Pooled Analysis of Gender and Trauma-Type Effects on Responsiveness to Treatment of PTSD With Venlafaxine Extended Release or Placebo

October 31, 2008

, , , et al
JCP
Letter to the Editor

Reply to More on Placebo Response

December 14, 2007

, , , et al
JCP
Original Research

Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram

November 15, 2006

, , , et al
JCP
Original Research

What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?

September 15, 2006

, , , et al
JCP
Article

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

June 15, 2006

, , , et al
JCP
Article

Symptoms of Fatigue and Sleepiness in Major Depressive Disorder

June 15, 2006

,
JCP
Original Research

Estimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey.

February 15, 2006

, , , et al
JCP
Article

Consensus Statement on Panic Disorder From the International Consensus Group on Depression and Anxiety

August 1, 1998

, , , et al
JCP
Article

The Side Effect Burden Associated With Drug Treatment of Panic Disorder

July 1, 1998

,

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe